DocMorris (formerly Zur Rose Group AG )
- Company typePublic
- Founded2023
- HeadquartersFrauenfeld, Switzerland
- Headcount1,001–5,000
- GTM typeB2B and B2C
- OfferingDigital Commerce or Content
What DocMorris (formerly Zur Rose Group AG ) does
DocMorris AG (formerly Zur Rose Group AG, rebranded 2023) is a Swiss-listed digital health platform (SIX: DOCM) headquartered in Frauenfeld, Switzerland, operating one of Europe's largest online pharmacies. Founded in 1993, the company serves over 12.6 million active customers across Germany, the Netherlands, Spain, France, Portugal, and Switzerland with a workforce of approximately 1,600 employees drawn from 65 nations. Its vision is to provide a single platform connecting patients and customers with doctors, pharmacies, and health insurers.
The company's core product surface is anchored on a digital pharmacy platform for prescription (Rx) and over-the-counter (OTC) medicines, supplemented by a marketplace model with 1,500+ partner pharmacies and sellers that extends product assortment across Europe. Underlying technology includes e-prescription handling, a state-of-the-art 20,000+ square meter logistics hub in Heerlen, Netherlands (purpose-built for the German E-Rezept mandate effective January 1, 2024), the TeleClinic telemedicine subsidiary (acquired 2020) with roughly 1,500 active doctors and over 1.6 million completed telemedical treatments, and an AI Health Companion launched in 2025. The DocMorris Ratgeber serves as a content hub for chronic-care journeys. Sub-brands include PromoFarma (Spain/France), DoctiPharma (France), and brand cooperations with medpex and Apotal in Germany.
DocMorris generates revenue through multiple streams: transaction-based sales of Rx and OTC medicines (CHF 1,186 million in external revenue for 2024/2025, the dominant stream), marketplace commissions on third-party partner sales, high-margin Digital Services including telemedicine and chronic-care programs (growing 63.1% in Q1 2026), and private-label OTC products. The go-to-market combines a digital-first, app-led consumer motion with enterprise partnerships targeting health insurers, pharmaceutical companies, and doctor networks. The company is progressing toward profitability with adjusted EBITDA losses narrowing to CHF -6.3 million in Q1 2026 from CHF -16.1 million a year earlier, targeting EBITDA breakeven by end of 2026 and positive free cash flow in 2027, supported by an AI-First cost-out program.
DocMorris (formerly Zur Rose Group AG ) firmographics
Firmographics- Name
- DocMorris (formerly Zur Rose Group AG )
- Legal name
- DocMorris AG
- Website
- https://corporate.docmorris.com
- Company type
- Public
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Ownership category
- akta.pro rank
DocMorris (formerly Zur Rose Group AG ) industry classification
Industry- Product category
- Online Pharmacy
- NAICS
- Pharmacies and Drug Retailers (45611), Pharmacies and Drug Retailers (456110), Offices of Physicians (62111), Offices of Physicians (6211)
- SIC
- Retail-Drug Stores And Proprietary Stores (5912), Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA)
- akta.pro secondary industries
- Pharmacy & Health Essentials Delivery (CRAFAFAI), Telepharmacy & Prescription Fulfillment Marketplaces (HLALALAF), Health, Wellness & Pharmacy Marketplaces (CRAFABAF)
Keywords
Where DocMorris (formerly Zur Rose Group AG ) is headquartered
LocationHeadquarters
- HQ city
- Frauenfeld
- HQ country
- Switzerland
- HQ region
- Europe
Offices6 records
Markets served
DocMorris (formerly Zur Rose Group AG ) business model
Business model- GTM type
- B2B and B2C
- Offering type
- Digital Commerce or Content
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Online Pharmacy (Rx & OTC): Core revenue stream from prescription medicines (Rx) and over-the-counter (OTC) products, including health, beauty, and personal care (BPC) products. The Rx business saw 30.4% growth in Q1 2026. The company generated CHF 1,186 million in external revenue in 2024.
- Marketplace Services: Marketplace model with over 1,500 partner pharmacies and sellers expanding the product catalogue. Revenue derived from marketplace commissions and transaction take rates on products sold by third-party partners.
- Digital Services: High-margin digital services segment growing 63.1% in Q1 2026, including telemedicine via Teleclinic, professional health services for doctors, health insurers, and pharmaceutical companies, as well as the DocMorris Ratgeber platform.
- Private Label Products: Own-brand products including nutritional supplements, painkillers, first-aid products, and other OTC medicines complementing the core offering.
Go-to-market motion3 records
Distribution channels8 records
Marketing channels6 records
DocMorris (formerly Zur Rose Group AG ) product offering
Product offeringCore offering
DocMorris operates a digital health ecosystem combining an online pharmacy (Rx and OTC medicines, health, beauty, and personal care products), a marketplace with 1,500+ partner pharmacies and sellers, telemedicine through its TeleClinic subsidiary, and professional health services for insurers and pharmaceutical companies. The platform processes e-prescriptions, supports app-first workflows, and delivers same-day via DocMorris Express, serving over 12 million active customers across Germany, Spain, France, the Netherlands, Portugal, and Switzerland.
Product overview
DocMorris operates as a digital health ecosystem platform consisting of three main business areas: Online Pharmacy (core prescription and OTC medicines), Marketplace Services (with over 1,500 partner pharmacies offering assortment expansion and DocMorris Express same-day delivery), and Professional Health Services (connecting doctors via TeleClinic telemedicine, pharmaceutical companies through the DocMorris Ratgeber digital hub, and health insurers with automated prescribing and billing services). The platform serves over 12 million active customers across Germany, Spain, France, Netherlands, Portugal, and Switzerland, integrating e-prescription handling, telehealth consultations, and AI-powered health support through the AI Health Companion. The portfolio includes main brand DocMorris, sub-brands PromoFarma, DoctiPharma, and TeleClinic, plus brand partnerships with medpex and Apotal.
Differentiator
Problem solved
Functional benefit
Brands
- PromoFarma by DocMorris: Online pharmacy and health marketplace brand serving Spain and France markets.
- DoctiPharma
- TeleClinic
- Apotal
- medpex
- DocMorris Express
Products and services
- DocMorris Online Pharmacy
- PromoFarma by DocMorris
- TeleClinic
- DoctiPharma
- medpex
- Apotal
- DocMorris Express
- DocMorris Ratgeber
- AI Health Companion
- Digital Services for Health Insurers and Pharma Companies
Quantifiable outcome
- Revenue grew 11.1% in full-year 2025; Q1 2026 saw 10.7% year-over-year revenue growth
- +5 more outcomes
Companies that use DocMorris (formerly Zur Rose Group AG )
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles5 records
DocMorris (formerly Zur Rose Group AG ) technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature6 records
DocMorris (formerly Zur Rose Group AG ) partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered subsidiary, core and minor.
- eHealth-Tec GmbHsubsidiaryeHealth-Tec GmbH, based in Berlin, is a wholly-owned subsidiary of DocMorris AG providing digital health technology integration services.
- TeleClinic GmbHcoreTeleClinic GmbH, based in Munich, is a DocMorris subsidiary operating one of Germany's leading telemedicine platforms. Approximately 1,500 doctors actively use the service, which has facilitated over 1.6 million telemedical treatments.
- DocMorris N.V.subsidiaryDocMorris N.V., based in Heerlen, Netherlands, serves as DocMorris AG's EU representation and operational hub, operating the logistics center and European operations.
- PromoFarma Ecom, S.l.subsidiaryPromoFarma Ecom, S.l., based in Barcelona, operates the Promofarma marketplace brand, DocMorris's online health and beauty marketplace in Spain and France.
- Doctipharma SASsubsidiaryDoctipharma SAS, based in Paris, is DocMorris's subsidiary operating the DoctiPharma online pharmacy brand in France.
- Marketplace Partners (1,500+ pharmacies and sellers)coreOver 1,500 partner pharmacies and sellers across Europe expand DocMorris's product catalogue, enabling assortment expansion and faster delivery options for patients and customers. Partners operate under the DocMorris marketplace model.
- Last-Mile Delivery PartnerscoreDocMorris partners with last-mile delivery providers to enable same-day delivery via the DocMorris Express service, increasing customer convenience and competitive differentiation.
- medpex (online pharmacy brand cooperation)minorBrand cooperation with medpex, a German online pharmacy, complements DocMorris's service portfolio in Germany, expanding reach and customer access.
- Apotal (online pharmacy brand cooperation)minorBrand cooperation with Apotal, a German online pharmacy, complements DocMorris's service portfolio, further expanding its reach in the German market.
- Pharmaceutical Companies (digital treatment pathway partners)coreDocMorris partners with pharmaceutical companies to improve digital health journeys for patients, combining e-commerce and telehealth expertise with leading treatment providers' experience for various health conditions. Partnerships are manifested through the DocMorris Ratgeber digital hub.
- Health Insurers (Germany)coreDocMorris provides health insurers with comprehensive services including medication ordering and management, automated prescribing, direct billing, and qualified pharmaceutical advice, making an active contribution to patient health outcomes.
- Teleclinic Doctors (c. 1,500 physicians)coreApproximately 1,500 doctors actively use the Teleclinic telemedicine service to connect patients with physicians across Germany, completing over 1.6 million telemedical consultations.
Scale indicators13 records
Recent moves5 records
Expansion highlights5 records
DocMorris (formerly Zur Rose Group AG ) competitors and assessment
Company assessmentMarket position
Competitive moat6 records
Key highlights7 records
Customer concentration
DocMorris (formerly Zur Rose Group AG ) social profiles
Digital presenceDocMorris (formerly Zur Rose Group AG ) financial estimates
Financial estimateRevenue estimate
Valuation estimate
DocMorris (formerly Zur Rose Group AG ) leadership team
Management profileNumber of profiles
Profiles20 records
DocMorris (formerly Zur Rose Group AG ) subsidiaries and ownership
Company hierarchySubsidiaries5 records
DocMorris (formerly Zur Rose Group AG ) funding detail
Funding detailFunding overview
Funding rounds4 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DocMorris (formerly Zur Rose Group AG ) M&A and investment
M&A and investmentM&A4 records
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DocMorris (formerly Zur Rose Group AG )
What does DocMorris (formerly Zur Rose Group AG ) do?
DocMorris operates a digital health ecosystem combining an online pharmacy (Rx and OTC medicines, health, beauty, and personal care products), a marketplace with 1,500+ partner pharmacies and sellers, telemedicine through its TeleClinic subsidiary, and professional health services for insurers and pharmaceutical companies. The platform processes e-prescriptions, supports app-first workflows, and delivers same-day via DocMorris Express, serving over 12 million active customers across Germany, Spain, France, the Netherlands, Portugal, and Switzerland.
Is DocMorris (formerly Zur Rose Group AG ) a public or private company?
DocMorris (formerly Zur Rose Group AG ) is a public company. It is classified as public and is currently operating.
When was DocMorris (formerly Zur Rose Group AG ) founded?
DocMorris (formerly Zur Rose Group AG ) was founded in 2023. It employs 1,001 to 5,000 people.
Where is DocMorris (formerly Zur Rose Group AG ) based?
DocMorris (formerly Zur Rose Group AG ) is headquartered in Frauenfeld, Switzerland, in the Europe region.
How does DocMorris (formerly Zur Rose Group AG ) make money?
Four revenue lines are on record. Online Pharmacy (Rx & OTC) is the primary driver. The others are marketplace Services, digital Services and private Label Products.
Does DocMorris (formerly Zur Rose Group AG ) have an API?
No public API is recorded for DocMorris (formerly Zur Rose Group AG ).
What industry is DocMorris (formerly Zur Rose Group AG ) in?
DocMorris (formerly Zur Rose Group AG )'s product category is Online Pharmacy. Its primary akta.pro industry code is HLALAIAA, DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription), with a secondary code of CRAFAFAI, Pharmacy & Health Essentials Delivery. Its NAICS code is 45611 and its SIC code is 5912.